DXC in Advanced Talks to Sell Insurance Software Unit

DXC Technology is in advanced talks to sell its insurance software unit to Eldridge Industries for approximately $2.4 billion, according to sources. The sale would simplify DXC's portfolio and allow Eldridge to combine the unit with its existing Zinnia platform. Neither company has commented on the reports.

Original reporting
Published Oct 24, 2026, 8:34 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 24, 2026, 8:48 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
DXC in Advanced Talks to Sell Insurance Software Unit — source image
Decision brief

The 30-second read

$DXCNeutralHigh
01

Why it matters

The transaction, if completed, would remove a legacy line of business and provide a sizable cash infusion, affecting DXC's balance sheet and earnings outlook.

02

Market read

First‑report M&A news with a $2.4 billion valuation, likely to move DXC stock in the short term.

03

What to watch

Potential synergies for Eldridge/Zinnia and the cash proceeds could fund higher‑growth initiatives for DXC.

Relevance 8/10Novelty 8/10Timing: in the coming weeks

Background

DXC has been reshaping its portfolio after years of declining revenue; the insurance software unit is a non‑core asset.

Company-level read

Ticker impact

$DXCNeutralHigh confidence
Context

DXC Technology is in advanced talks to sell its insurance software unit for about $2.4 billion.

Expected impact

likely downside as the market prices in the sale uncertainty and revenue loss.

Evidence & confidence

M&A talks of this size are material; the deal is not certain and may cause short‑term volatility.

Market effects

May signal consolidation in the insurance‑tech space, prompting peers to consider similar sales.

Primarily U.S. tech and insurance sectors; limited broader regional effect.

Highlights private‑capital interest in insurance software globally.

Counterpoint

The sale could be seen as a strategic focus that improves DXC's long‑term margins, supporting upside.

Key entities

  • DXC Technology

    U.S. IT services firm exploring sale of its insurance software unit.

  • Eldridge Industries

    Potential buyer seeking to combine the unit with its Zinnia platform.

Related articles

$DXCMedAI 8/10

Stifel maintains Hold on DXC Technology stock amid unit sale reports

Stifel reiterated a Hold rating and $10.50 price target on DXC Technology (NYSE:DXC) amid reports of potential insurance unit sale to Eldridge for $2.4B. DXC's insurance unit generated $1.3B in LTM revenue. DXC's stock trades at $14.26, with a P/E ratio of 20.18. The company reported mixed Q1 2027 results, missing EPS estimates but beating revenue forecasts. TD Cowen raised its price target to $12.00, maintaining a Hold rating.

$DXCMed

Why DXC (DXC) Stock Is Trading Up Today

DXC Technology (NYSE: DXC) shares rose 4.6% after announcing a partnership with LangChain to deploy AI agents. The collaboration leverages DXC's OASIS platform, which reportedly reduced resolution times by 95% in over 500 use cases. The stock later settled at $12.97, up 3.4%. DXC is down 7.9% year-to-date, trading 16% below its 52-week high.

$DXCMed

Is DXC Technology (DXC) Fairly Valued As Leadership Changes Put Execution Back In Focus?

DXC Technology (DXC) appointed new leaders for key business units. Shares closed at $11.39, up 3.17% in one day but down 19.11% year-to-date and 68.33% over five years. Analysts debate its valuation, with some calling it undervalued at $11.43 based on discounted cash flow analysis, citing strong bookings momentum. However, risks include declining revenue and profitability challenges.

$KDLow

Q2 Rundown: Kyndryl (NYSE:KD) Vs Other IT Services & Consulting Stocks

Kyndryl (KD) reported Q2 revenue of $3.62B, down 3.3% YoY, missing estimates by 0.7% but beating EPS. Gartner (IT) reported $1.68B revenue, up 1.8% YoY, beating estimates. Accenture (ACN) reported $18.72B revenue, up 5.6% YoY, in line with estimates but missed guidance. IBM (IBM) reported $17.16B revenue, up 1.1% YoY, missing estimates by 1.5%. DXC (DXC) reported $3.00B revenue, down 5.1% YoY, in line with estimates but missed EPS.